Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.3%

285 terminated/withdrawn out of 1753 trials

Success Rate

78.2%

-8.3% vs industry average

Late-Stage Pipeline

10%

167 trials in Phase 3/4

Results Transparency

51%

525 of 1025 completed trials have results

Key Signals

217 recruiting525 with results171 terminated114 withdrawn

Enrollment Performance

Analytics

N/A
852(59.7%)
Phase 2
229(16.0%)
Phase 1
130(9.1%)
Phase 4
107(7.5%)
Phase 3
60(4.2%)
Early Phase 1
49(3.4%)
1427Total
N/A(852)
Phase 2(229)
Phase 1(130)
Phase 4(107)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1753)

Showing 20 of 1753 trials
NCT05576896Phase 2Terminated

Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory

Role: lead

NCT04173169Phase 3Completed

Pre-IVF Treatment With a GnRH Antagonist in Women With Endometriosis

Role: collaborator

NCT02232516Phase 2Completed

Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma

Role: lead

NCT06630416Phase 2Recruiting

Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors

Role: lead

NCT05744739Phase 1Terminated

Tomivosertib in Relapsed or Refractory Acute Myeloid Leukemia (AML)

Role: lead

NCT07604272Phase 1Not Yet Recruiting

Reversing InGuinal Hernia Trial: The Evaluation of Sex Hormones to Reverse Inguinal Hernias in Males

Role: lead

NCT07641244Not ApplicableRecruiting

Experimental Evidence of the Impact of Parental Income on Child Mental Health and Neuroimmune Function

Role: lead

NCT07637630Not ApplicableRecruiting

Trial in HPV Prevention for the U.S. Vietnamese Community

Role: lead

NCT02242097Phase 2Completed

Ibrutinib After Intensive Induction in Treating Patients With Previously Untreated Mantle Cell Lymphoma

Role: lead

NCT06912776Not ApplicableRecruiting

Novel Visual Education Tool to Improve Recognition and Reporting of Postpartum Urgent Maternal Warning Signs

Role: lead

NCT06844305Not ApplicableNot Yet Recruiting

Personalized Prosthetic Foot Prescription and Rehabilitation for Veterans With Lower Limb Loss

Role: lead

NCT07639528Phase 2Not Yet Recruiting

Preoperative Durvalumab, Cisplatin, Gemcitabine With or Without Futibatinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, OPTIC Trial

Role: lead

NCT07224165Not ApplicableRecruiting

Developing a Digital Intervention for Adolescent Nonsuicidal Self-injury

Role: lead

NCT05722444Not ApplicableCompleted

Sleep and Health Outcomes in Women With Heavy Menses

Role: lead

NCT03577327Recruiting

The Gut and Skin Microbiome in Vitiligo Disease Progression

Role: lead

NCT05351229Phase 4Recruiting

Intrathecal Morphine for Analgesia in Video-assisted and Robotic-assisted Thoracic Surgery

Role: lead

NCT07631286Not ApplicableRecruiting

Ejaculatory-Sparing HoLEP vs Standard HoLEP

Role: lead

NCT06949644Not ApplicableRecruiting

Pupillometry in Delayed Sleep Wake Phase Disorder

Role: lead

NCT07041775Not ApplicableRecruiting

MINT Conditioning to Improve Gait

Role: lead

NCT07632742Not ApplicableRecruiting

Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial

Role: lead